| Drug Name |
Fosaprepitant dimeglumine |
| Drug ID |
BADD_D00963 |
| Description |
Fosaprepitant is an intravenously administered antiemetic drug. It is a prodrug of Aprepitant. It aids in the prevention of acute and delayed nausea and vomiting associated with chemotherapy treatment. |
| Indications and Usage |
For the prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapy. |
| Marketing Status |
Prescription; Discontinued |
| ATC Code |
A04AD12 |
| DrugBank ID |
DB06717
|
| KEGG ID |
D06597
|
| MeSH ID |
C579707
|
| PubChem ID |
136086851
|
| TTD Drug ID |
Not Available
|
| NDC Product Code |
0143-9384; 31722-165; 0006-3061; 67184-0540; 70447-0001; 63552-011; 55150-299; 16714-248; 68001-523; 70625-300; 71731-5111; 76339-141; 66039-904; 61662-0007; 0338-0008; 70860-783; 70860-782; 65085-0060; 14501-0064; 0143-9428; 65977-0080; 0781-3484; 52133-0045; 59651-111 |
| Synonyms |
fosaprepitant | Emend for injection | fosaprepitant dimeglumine | L 785,298 | L785,298 | L-785,298 |
